MI
Mirae Asset Small Cap Fund Direct Growth
Latest NAV
+9.54% 1Y
Sign In to Add to Portfolio
Benchmark: Nifty Smallcap 250 TRI
Expense ratio
0.67%
AUM
₹5,717 Cr
Min SIP
₹99
Min lump sum
₹5,000
1Y
+9.54%
3Y (ann.)
+0.00%
5Y (ann.)
+0.00%
Launched
Jan 2025
Where the NAV sits & how risky it is
₹12.58
52-week range
at 80%
₹12.58
Low 23 Mar 2026₹10.28
High 08 Sep 2026₹13.17
Risk level
Very High
Low
Very high
NAV history
03 Feb 2025
Since inception
05 Oct 2026
Returns by period
1W
-2.57%
1M
-3.75%
3M
+1.34%
6M
+18.63%
1Y
+9.54%
3Y
+0.00%
5Y
+0.00%
3Y and 5Y returns are annualised.
Return calculator
You invest
—
Est. gain
—
Est. value
—
Invested Gain
Invested
Projected value
min SIP ₹99
Estimate only. It assumes the selected past return repeats every year; 3Y and 5Y figures are taken as annualised. Actual returns vary and are not guaranteed.
Where your money goes
AS OF 31 MAY 2026
Equity 99.24%
Cash & other 2.53%
Sector split
Country split
Top 5 hold 13.3%
Top 10 hold 24.0%
85 equity holdings
Equity holdings
(top 30)
| # | Holding | Sector | Country | Weight | YTD |
|---|---|---|---|---|---|
| 1 | Welspun Corp
INE191B01025 |
Basic Materials Steel |
India |
3.02%
|
+72.19% |
| 2 | Kirloskar Oil Engines
INE146L01010 |
Industrials Specialty Industrial Machinery |
India |
2.93%
|
+55.22% |
| 3 | Cholamandalam Financial Holdings
INE149A01033 |
Financial Services Credit Services |
India |
2.57%
|
-15.92% |
| 4 | Karur Vysya Bank
INE036D01028 |
Financial Services Banks - Regional |
India |
2.53%
|
+9.52% |
| 5 | Krishna Institute of Medical Sciences
INE967H01025 |
Healthcare Medical Care Facilities |
India |
2.24%
|
+29.00% |
| 6 | Voltamp Transformers
INE540H01012 |
Industrials Electrical Equipment & Parts |
India |
2.22%
|
+23.78% |
| 7 | Dr. Lal Path Labs
INE600L01024 |
Healthcare Diagnostics & Research |
India |
2.19%
|
+8.26% |
| 8 | Anthem Biosciences
INE0CZ201020 |
Healthcare Biotechnology |
India |
2.14%
|
+21.06% |
| 9 | Timken
INE325A01013 |
Industrials Tools & Accessories |
India |
2.11%
|
+17.55% |
| 10 | Neuland Laboratories
INE794A01010 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
2.09%
|
+13.33% |
About this scheme
The investment objective of the scheme is to generate capital appreciation by investing predominantly in small cap stocks. From time to time, the fund manager will also seek participation in other equity and equity related securities to achieve optimal portfolio construction. There is no assurance that the investment objective of the Scheme will be achieved.
Fund manager(s): Varun Goel
Exit load: Exit Load for units in excess of 15% of the investment,1% will be charged for redemption within 365 days.
Scheme snapshot
VR Rating
MS Rating
Plan
Growth
Type
DIRECT
Inception
31 Jan 2025
Lump-sum min
₹5,000
SIP
Purchase
Switch
STP
SWP
Similar schemes
RANKED BY 1Y RETURN
Nippon India Taiwan Equity Fund Direct Growth
1▲ 112.0 pts ahead of this fund
Franklin Asian Equity Fund Direct Growth
2▲ 23.8 pts ahead of this fund
Nippon India Japan Equity Fund - Direct Plan - Growth Plan - Bonus Option
3▲ 21.1 pts ahead of this fund
Nippon India Japan Equity Fund Direct Growth
4▲ 21.1 pts ahead of this fund
Bank of India Small Cap Fund Direct Growth
5▲ 19.7 pts ahead of this fund
TRUSTMF Small Cap Fund Direct Growth
6▲ 19.6 pts ahead of this fund